This inventor holds 2 USPTO granted patents. Top assignees: Japan Tabacco Inc., Japan Tobacco Inc.. Active years: 2002-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Takatsuki, JP (2002)
- Takatsuki-cho, JP (2005)
Company Filing History:
Years Active: 2002-2005
Title: Innovations of Hideki Yamada
Introduction
Hideki Yamada is a notable inventor based in Takatsuki-cho, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as nociceptin antagonists. With a total of 2 patents, Yamada's work has the potential to impact pain management therapies.
Latest Patents
Yamada's latest patents focus on amide derivatives and nociceptin antagonists. The present invention relates to a compound of the formula [1'] wherein R is lower alkyl optionally substituted by hydroxy, amino, and similar groups. Ring B can be phenyl, thienyl, and other structures, while E represents a single bond, —O—, —S—, and similar connections. Ring G is defined as aryl or heterocyclic groups. The compound [1'] demonstrates nociceptin antagonistic action, providing analgesic effects against sharp pain, such as postoperative pain. This invention also highlights the use of certain amide derivatives, including compound [1'], as nociceptin antagonists or analgesics.
Career Highlights
Throughout his career, Yamada has worked with prominent companies, including Japan Tobacco Inc. and Japan Tabacco Inc. His innovative work has contributed to advancements in pharmaceutical research and development.
Collaborations
Yamada has collaborated with notable individuals in his field, including Hisashi Shinkai and Takao Ito. These partnerships have likely enhanced the scope and impact of his research.
Conclusion
Hideki Yamada's contributions to the field of pharmaceuticals, particularly through his patents on nociceptin antagonists, showcase his innovative spirit and dedication to improving pain management. His work continues to influence the development of new therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
